Zhang J, Wang P, Ren Y, Chen L, et al. Chemoradiotherapy with temozolomide vs. radiotherapy alone in patients with IDH wild-type and TERT promoter mutation histological grade 2/3 gliomas: An extension retrospective analysis of a randomized controlled trial. Cancer 2025;131:e70171.
PMID: 41328764